how was glp-1 discovered Timeline of discovery and clinical development. (a) Key events in The transformative breakthroughs in GLP-1

2,3 In addition to these mechanisms, GLP-1 RAs also delay gastric emptying, thereby contributing to enhanced postprandial glucose regulation and increased satiety, ultimately supporting reduced caloric intake and weight management

Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early weight-loss and metabolic data in Phase 2 trials, but it is not yet approved in the UK and carries notable side effects and safety uncertainties

Iran J Public Health

Discontinuation rates in trials range from 2040% due to tolerability issues, making this medication challenging for sensitive individuals

Food noise : Many users report less obsessive thinking about food

Heres how GLP-1 can support your journey toward better health and a more youthful, vibrant life: When you eat, your body naturally releases GLP-1 from specialized intestinal cells, signaling your pancreas to release insulin